Congenital heart block (CHB) has been described for a century and rela
ted to the presence of maternal autoimmune disease for three decades,
but little is understood about its mechanism. To explore the pathophys
iology of CHB, technologies in both basic and clinical electrophysiolo
gy are being developed and applied. Human fetal rhythm is currently in
ferred from cardiac mechanical events by using fetal ultrasound, allow
ing for the detection of second and third-degree heart block. Fetal el
ectrocardiography is being explored to assess its feasibility as a cli
nical tool to detect fetal first-degree block in the mid trimester. Se
quential composite digital recordings from the maternal abdomen are ma
de every 4 weeks from pregnancies at risk for congenital heart block.
Filtering and averaging techniques are used to enhance the fetal signa
l. So far, these techniques have produced a fetal QRS complex trigger
signal for use in three-dimensional fetal echocardiography. Because th
e human fetus cannot be studied directly, a Langendorff rabbit model o
f CHB has been developed. With 5-10 mt of human serum in 150-300 mt of
Krebs solution. prolongation of the Wenckebach second-degree atrioven
tricular block cycle length occurred. This was reproduced by using ser
um from seven of eight CHB mothers as compared with none of six contro
ls mothers.